| Year |
Citation |
Score |
| 2023 |
Pan Y, Phillips JW, Zhang BD, Noguchi M, Kutschera E, McLaughlin J, Nesterenko PA, Mao Z, Bangayan NJ, Wang R, Tran W, Yang HT, Wang Y, Xu Y, Obusan MB, et al. IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing. Proceedings of the National Academy of Sciences of the United States of America. 120: e2221116120. PMID 37192158 DOI: 10.1073/pnas.2221116120 |
0.424 |
|
| 2020 |
Xu S, Kim J, Tang Q, Chen Q, Liu J, Xu Y, Fu X. CAS9 is a genome mutator by directly disrupting DNA-PK dependent DNA repair pathway. Protein & Cell. PMID 32170574 DOI: 10.1007/S13238-020-00699-6 |
0.311 |
|
| 2019 |
Liu X, Wang M, Jiang T, He J, Fu X, Xu Y. IDO1 maintains pluripotency of primed human embryonic stem cells by promoting glycolysis. Stem Cells (Dayton, Ohio). PMID 31145821 DOI: 10.1002/Stem.3044 |
0.346 |
|
| 2019 |
Kim J, Yu L, Chen W, Xu Y, Wu M, Todorova D, Tang Q, Feng B, Jiang L, He J, Chen G, Fu X, Xu Y. Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation. Cancer Cell. PMID 30712844 DOI: 10.1016/J.Ccell.2018.12.012 |
0.31 |
|
| 2018 |
Lee SY, Park JH, Jeong S, Kim BY, Kang YK, Xu Y, Chung SK. K120R mutation inactivates p53 by creating an aberrant splice site leading to nonsense-mediated mRNA decay. Oncogene. PMID 30348990 DOI: 10.1038/S41388-018-0542-3 |
0.307 |
|
| 2018 |
Kim J, Yu S, Xu Y. The roles of NANOG in tumorigenesis. Molecular & Cellular Oncology. 5: e1074334. PMID 30250875 DOI: 10.1080/23723556.2015.1074334 |
0.333 |
|
| 2018 |
Jin R, Yang L, Zheng M, Xu Y, Li C, Liu G. Source identification and quantification of chlorinated and brominated polycyclic aromatic hydrocarbons from cement kilns co-processing solid wastes. Environmental Pollution (Barking, Essex : 1987). 242: 1346-1352. PMID 30125845 DOI: 10.1016/j.envpol.2018.08.025 |
0.305 |
|
| 2018 |
Yang X, Zhou J, He J, Liu J, Wang H, Liu Y, Jiang T, Zhang Q, Fu X, Xu Y. An Immune System-Modified Rat Model for Human Stem Cell Transplantation Research. Stem Cell Reports. PMID 29983387 DOI: 10.1016/J.Stemcr.2018.06.004 |
0.3 |
|
| 2018 |
Chen J, Li W, Cui K, Ji K, Xu S, Xu Y. Artemisitene suppresses tumorigenesis by inducing DNA damage through deregulating c-Myc-topoisomerase pathway. Oncogene. PMID 29795406 DOI: 10.1038/S41388-018-0331-Z |
0.34 |
|
| 2017 |
Kim J, Xu S, Xiong L, Yu L, Fu X, Xu Y. SALL4 promotes glycolysis and chromatin remodeling via modulating HP1α-Glut1 pathway. Oncogene. PMID 28759035 DOI: 10.1038/Onc.2017.265 |
0.351 |
|
| 2017 |
Liu X, Li W, Fu X, Xu Y. The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives. Frontiers in Immunology. 8: 645. PMID 28626459 DOI: 10.3389/Fimmu.2017.00645 |
0.333 |
|
| 2017 |
Saunders A, Li D, Faiola F, Huang X, Fidalgo M, Guallar D, Ding J, Yang F, Xu Y, Zhou H, Wang J. Context-Dependent Functions of NANOG Phosphorylation in Pluripotency and Reprogramming. Stem Cell Reports. PMID 28457890 DOI: 10.1016/J.Stemcr.2017.03.023 |
0.332 |
|
| 2017 |
Wang RM, Johnson TD, He J, Rong Z, Wong M, Nigam V, Behfar A, Xu Y, Christman KL. Humanized mouse model for assessing the human immune response to xenogeneic and allogeneic decellularized biomaterials. Biomaterials. 129: 98-110. PMID 28334641 DOI: 10.1016/J.Biomaterials.2017.03.016 |
0.325 |
|
| 2017 |
He J, Rong Z, Fu X, Xu Y. A safety checkpoint to eliminate cancer risk of the immune evasive cells derived from human embryonic stem cells. Stem Cells (Dayton, Ohio). PMID 28090751 DOI: 10.1002/Stem.2568 |
0.332 |
|
| 2017 |
Wang RM, He J, Xu Y, Christman KL. Humanized mouse model for evaluating biocompatibility and human immune cell interactions to biomaterials Drug Discovery Today: Disease Models. 24: 23-29. DOI: 10.1016/J.Ddmod.2018.06.002 |
0.305 |
|
| 2016 |
Fu X, Cui K, Yi Q, Yu L, Xu Y. DNA repair mechanisms in embryonic stem cells. Cellular and Molecular Life Sciences : Cmls. PMID 27614628 DOI: 10.1007/S00018-016-2358-Z |
0.359 |
|
| 2015 |
Todorova D, Kim J, Hamzeinejad S, He J, Xu Y. Immune Microenvironment Determines the Immunogenicity of iPSC Derivatives. Stem Cells (Dayton, Ohio). PMID 26439188 DOI: 10.1002/Stem.2227 |
0.337 |
|
| 2015 |
Luo Y, Wang X, Wang H, Xu Y, Wen Q, Fan S, Zhao R, Jiang S, Yang J, Liu Y, Li X, Xiong W, Ma J, Peng S, Zeng Z, et al. High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel. Plos One. 10: e0138955. PMID 26406239 DOI: 10.1371/Journal.Pone.0138955 |
0.309 |
|
| 2015 |
Zhao T, Zhang ZN, Westenskow PD, Todorova D, Hu Z, Lin T, Rong Z, Kim J, He J, Wang M, Clegg DO, Yang YG, Zhang K, Friedlander M, Xu Y. Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells. Cell Stem Cell. 17: 353-9. PMID 26299572 DOI: 10.1016/J.Stem.2015.07.021 |
0.364 |
|
| 2015 |
Kim J, Liu Y, Qiu M, Xu Y. Pluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells. Oncogene. PMID 26073077 DOI: 10.1038/Onc.2015.205 |
0.393 |
|
| 2015 |
Xiong J, Todorova D, Su NY, Kim J, Lee PJ, Shen Z, Briggs SP, Xu Y. Stemness factor Sall4 is required for DNA damage response in embryonic stem cells. The Journal of Cell Biology. 208: 513-20. PMID 25733712 DOI: 10.1083/Jcb.201408106 |
0.358 |
|
| 2015 |
Zhu S, Rong Z, Lu X, Xu Y, Fu X. Gene Targeting Through Homologous Recombination in Monkey Embryonic Stem Cells Using CRISPR/Cas9 System. Stem Cells and Development. 24: 1147-9. PMID 25579438 DOI: 10.1089/Scd.2014.0507 |
0.4 |
|
| 2015 |
Gao R, Chen S, Kobayashi M, Yu H, Zhang Y, Wan Y, Young SK, Soltis A, Yu M, Vemula S, Fraenkel E, Cantor A, Antipin Y, Xu Y, Yoder MC, et al. Bmi1 promotes erythroid development through regulating ribosome biogenesis. Stem Cells (Dayton, Ohio). 33: 925-38. PMID 25385494 DOI: 10.1002/Stem.1896 |
0.379 |
|
| 2014 |
Li Z, Lu H, Yang W, Yong J, Zhang ZN, Zhang K, Deng H, Xu Y. Mouse SCNT ESCs have lower somatic mutation load than syngeneic iPSCs. Stem Cell Reports. 2: 399-405. PMID 24749065 DOI: 10.1016/J.Stemcr.2014.02.005 |
0.317 |
|
| 2014 |
Chung SK, Zhu S, Xu Y, Fu X. Functional analysis of the acetylation of human p53 in DNA damage responses. Protein & Cell. 5: 544-51. PMID 24691905 DOI: 10.1007/S13238-014-0048-X |
0.378 |
|
| 2014 |
Rong Z, Zhu S, Xu Y, Fu X. Homologous recombination in human embryonic stem cells using CRISPR/Cas9 nickase and a long DNA donor template. Protein & Cell. 5: 258-60. PMID 24622843 DOI: 10.1007/S13238-014-0032-5 |
0.308 |
|
| 2014 |
Fu X, Rong Z, Zhu S, Wang X, Xu Y, Lake BB. Genetic approach to track neural cell fate decisions using human embryonic stem cells. Protein & Cell. 5: 69-79. PMID 24474203 DOI: 10.1007/S13238-013-0007-Y |
0.327 |
|
| 2014 |
Rong Z, Wang M, Hu Z, Stradner M, Zhu S, Kong H, Yi H, Goldrath A, Yang YG, Xu Y, Fu X. An effective approach to prevent immune rejection of human ESC-derived allografts. Cell Stem Cell. 14: 121-30. PMID 24388175 DOI: 10.1016/J.Stem.2013.11.014 |
0.354 |
|
| 2014 |
Zhang ZN, Chung SK, Xu Z, Xu Y. Oct4 maintains the pluripotency of human embryonic stem cells by inactivating p53 through Sirt1-mediated deacetylation. Stem Cells (Dayton, Ohio). 32: 157-65. PMID 24038750 DOI: 10.1002/Stem.1532 |
0.361 |
|
| 2013 |
Lu X, Liu D, Xu Y. The gain of function of p53 cancer mutant in promoting mammary tumorigenesis Oncogene. 32: 2900-2906. PMID 22824795 DOI: 10.1038/Onc.2012.299 |
0.334 |
|
| 2012 |
Zhang ZN, Xu Y. Progress and bottleneck in induced pluripotency. Cell Regeneration (London, England). 1: 5. PMID 25408868 DOI: 10.1186/2045-9769-1-5 |
0.366 |
|
| 2012 |
Westenskow PD, Moreno SK, Krohne TU, Kurihara T, Zhu S, Zhang ZN, Zhao T, Xu Y, Ding S, Friedlander M. Using flow cytometry to compare the dynamics of photoreceptor outer segment phagocytosis in iPS-derived RPE cells. Investigative Ophthalmology & Visual Science. 53: 6282-90. PMID 22871841 DOI: 10.1167/Iovs.12-9721 |
0.314 |
|
| 2012 |
Rong Z, Fu X, Wang M, Xu Y. A Scalable Approach to Prevent Teratoma Formation of Human Embryonic Stem Cells Journal of Biological Chemistry. 287: 32338-32345. PMID 22865887 DOI: 10.1074/Jbc.M112.383810 |
0.343 |
|
| 2012 |
Fu X, Xu Y. Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stability. Genome Medicine. 4: 55. PMID 22741526 DOI: 10.1186/Gm354 |
0.339 |
|
| 2012 |
Won KJ, Xu Z, Zhang X, Whitaker JW, Shoemaker R, Ren B, Xu Y, Wang W. Global identification of transcriptional regulators of pluripotency and differentiation in embryonic stem cells Nucleic Acids Research. 40: 8199-8209. PMID 22730289 DOI: 10.1093/Nar/Gks584 |
0.329 |
|
| 2012 |
Chen Z, Zhao T, Xu Y. The genomic stability of induced pluripotent stem cells. Protein & Cell. 3: 271-277. PMID 22528751 DOI: 10.1007/S13238-012-2922-8 |
0.347 |
|
| 2012 |
Lake BB, Fink J, Klemetsaune L, Fu X, Jeffers JR, Zambetti GP, Xu Y. Context-dependent enhancement of induced pluripotent stem cell reprogramming by silencing Puma. Stem Cells (Dayton, Ohio). 30: 888-97. PMID 22311782 DOI: 10.1002/Stem.1054 |
0.394 |
|
| 2011 |
Zhao T, Zhang Z, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells Nature. 474: 212-215. PMID 21572395 DOI: 10.1038/Nature10135 |
0.324 |
|
| 2011 |
Fu X, Xu Y. Self-renewal and scalability of human embryonic stem cells for human therapy. Regenerative Medicine. 6: 327-334. PMID 21548738 DOI: 10.2217/Rme.11.18 |
0.307 |
|
| 2010 |
Liu D, Ou L, Clemenson GD, Chao C, Lutske ME, Zambetti GP, Gage FH, Xu Y. Puma is required for p53-induced depletion of adult stem cells. Nature Cell Biology. 12: 993-8. PMID 20818388 DOI: 10.1038/Ncb2100 |
0.388 |
|
| 2010 |
Moretto-Zita M, Jin H, Shen Z, Zhao T, Briggs SP, Xu Y. Phosphorylation stabilizes Nanog by promoting its interaction with Pin1. Proceedings of the National Academy of Sciences of the United States of America. 107: 13312-7. PMID 20622153 DOI: 10.1073/Pnas.1005847107 |
0.335 |
|
| 2010 |
Song H, Chung SK, Xu Y. Modeling Disease in Human ESCs Using an Efficient BAC-Based Homologous Recombination System Cell Stem Cell. 6: 80-89. PMID 20074536 DOI: 10.1016/J.Stem.2009.11.016 |
0.316 |
|
| 2010 |
Zhao T, Xu Y. p53 and stem cells: new developments and new concerns Trends in Cell Biology. 20: 170-175. PMID 20061153 DOI: 10.1016/J.Tcb.2009.12.004 |
0.376 |
|
| 2010 |
Jankovic M, Robbiani DF, Dorsett Y, Eisenreich T, Xu Y, Tarakhovsky A, Nussenzweig A, Nussenzweig MC. Role of the translocation partner in protection against AID-dependent chromosomal translocations. Proceedings of the National Academy of Sciences of the United States of America. 107: 187-92. PMID 19966290 DOI: 10.1073/Pnas.0908946107 |
0.388 |
|
| 2010 |
Liu D, Song H, Xu Y. A common Gain of function of p53 cancer mutants in inducing genetic instability Oncogene. 29: 949-956. PMID 19881536 DOI: 10.1038/Onc.2009.376 |
0.332 |
|
| 2009 |
Deng W, Xu Y. Genome integrity: linking pluripotency and tumorgenicity. Trends in Genetics : Tig. 25: 425-7. PMID 19801173 DOI: 10.1016/J.Tig.2009.09.004 |
0.328 |
|
| 2009 |
Gaidarenko O, Xu Y. Transcription activity is required for p53-dependent tumor suppression. Oncogene. 28: 4397-4401. PMID 19767771 DOI: 10.1038/Onc.2009.290 |
0.372 |
|
| 2008 |
Hewitt SL, Farmer D, Marszalek K, Cadera E, Liang HE, Xu Y, Schlissel MS, Skok JA. Association between the Igk and Igh immunoglobulin loci mediated by the 3' Igk enhancer induces 'decontraction' of the Igh locus in pre-B cells. Nature Immunology. 9: 396-404. PMID 18297074 DOI: 10.1038/Ni1567 |
0.358 |
|
| 2008 |
Jenkins LM, Mazur SJ, Rossi M, Gaidarenko O, Xu Y, Appella E. Quantitative proteomics analysis of the effects of ionizing radiation in wild type and p53 K317R knock-in mouse thymocytes. Molecular & Cellular Proteomics : McP. 7: 716-27. PMID 18178582 DOI: 10.1074/Mcp.M700482-Mcp200 |
0.401 |
|
| 2007 |
Song H, Xu Y. Gain of Function of p53 Cancer Mutants in Disrupting Critical DNA Damage Response Pathways Cell Cycle. 6: 1570-1573. PMID 17598983 DOI: 10.4161/Cc.6.13.4456 |
0.33 |
|
| 2007 |
Song J, Chao C, Xu Y. Ser18 and Ser23 phosphorylation plays synergistic roles in activating p53-dependent neuronal apoptosis. Cell Cycle (Georgetown, Tex.). 6: 1412-4. PMID 17581277 DOI: 10.4161/Cc.6.12.4391 |
0.353 |
|
| 2007 |
Song H, Hollstein M, Xu Y. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nature Cell Biology. 9: 573-80. PMID 17417627 DOI: 10.1038/Ncb1571 |
0.381 |
|
| 2006 |
Feng L, Hollstein M, Xu Y. Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence. Cell Cycle (Georgetown, Tex.). 5: 2812-9. PMID 17172844 DOI: 10.4161/Cc.5.23.3526 |
0.4 |
|
| 2006 |
Chao C, Wu Z, Mazur SJ, Borges H, Rossi M, Lin T, Wang JY, Anderson CW, Appella E, Xu Y. Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage. Molecular and Cellular Biology. 26: 6859-69. PMID 16943427 DOI: 10.1128/Mcb.00062-06 |
0.588 |
|
| 2006 |
Inlay MA, Gao HH, Odegard VH, Lin T, Schatz DG, Xu Y. Roles of the Ig kappa light chain intronic and 3' enhancers in Igk somatic hypermutation. Journal of Immunology (Baltimore, Md. : 1950). 177: 1146-51. PMID 16818772 DOI: 10.4049/Jimmunol.177.2.1146 |
0.739 |
|
| 2006 |
Inlay MA, Lin T, Gao HH, Xu Y. Critical roles of the immunoglobulin intronic enhancers in maintaining the sequential rearrangement of IgH and Igk loci. The Journal of Experimental Medicine. 203: 1721-32. PMID 16785310 DOI: 10.1084/Jem.20052310 |
0.695 |
|
| 2006 |
Chao C, Herr D, Chun J, Xu Y. Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression. The Embo Journal. 25: 2615-22. PMID 16757976 DOI: 10.1038/Sj.Emboj.7601167 |
0.544 |
|
| 2005 |
Al Rashid ST, Dellaire G, Cuddihy A, Jalali F, Vaid M, Coackley C, Folkard M, Xu Y, Chen BP, Chen DJ, Lilge L, Prise KM, Bazett Jones DP, Bristow RG. Evidence for the direct binding of phosphorylated p53 to sites of DNA breaks in vivo. Cancer Research. 65: 10810-21. PMID 16322227 DOI: 10.1158/0008-5472.Can-05-0729 |
0.342 |
|
| 2005 |
Feng L, Lin T, Uranishi H, Gu W, Xu Y. Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Molecular and Cellular Biology. 25: 5389-95. PMID 15964796 DOI: 10.1128/Mcb.25.13.5389-5395.2005 |
0.376 |
|
| 2005 |
Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Molecular Cell. 18: 283-93. PMID 15866171 DOI: 10.1016/J.Molcel.2005.03.027 |
0.359 |
|
| 2005 |
Kang J, Ferguson D, Song H, Bassing C, Eckersdorff M, Alt FW, Xu Y. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression. Molecular and Cellular Biology. 25: 661-70. PMID 15632067 DOI: 10.1128/Mcb.25.2.661-670.2005 |
0.597 |
|
| 2005 |
Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E, Xu Y. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nature Cell Biology. 7: 165-71. PMID 15619621 DOI: 10.1038/Ncb1211 |
0.391 |
|
| 2004 |
Inlay MA, Tian H, Lin T, Xu Y. Important roles for E protein binding sites within the immunoglobulin kappa chain intronic enhancer in activating Vkappa Jkappa rearrangement. The Journal of Experimental Medicine. 200: 1205-11. PMID 15504821 DOI: 10.1084/Jem.20041135 |
0.67 |
|
| 2004 |
Woo RA, Jack MT, Xu Y, Burma S, Chen DJ, Lee PWK. DNA damage-induced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53 The Embo Journal. 23: 4877-4877. DOI: 10.1038/Sj.Emboj.7600514 |
0.307 |
|
| 2003 |
Inlay M, Xu Y. Epigenetic regulation of antigen receptor rearrangement. Clinical Immunology (Orlando, Fla.). 109: 29-36. PMID 14585273 DOI: 10.1016/S1521-6616(03)00199-2 |
0.668 |
|
| 2003 |
Chao C, Hergenhahn M, Kaeser MD, Wu Z, Saito S, Iggo R, Hollstein M, Appella E, Xu Y. Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses. The Journal of Biological Chemistry. 278: 41028-33. PMID 12909629 DOI: 10.1074/Jbc.M306938200 |
0.4 |
|
| 2003 |
Saito S, Yamaguchi H, Higashimoto Y, Chao C, Xu Y, Fornace AJ, Appella E, Anderson CW. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. The Journal of Biological Chemistry. 278: 37536-44. PMID 12860987 DOI: 10.1074/Jbc.M305135200 |
0.329 |
|
| 2002 |
Woo RA, Jack MT, Xu Y, Burma S, Chen DJ, Lee PW. DNA damage-induced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53. The Embo Journal. 21: 3000-8. PMID 12065413 DOI: 10.1093/Emboj/Cdf307 |
0.352 |
|
| 2002 |
Inlay M, Alt FW, Baltimore D, Xu Y. Essential roles of the kappa light chain intronic enhancer and 3' enhancer in kappa rearrangement and demethylation. Nature Immunology. 3: 463-8. PMID 11967540 DOI: 10.1038/Ni790 |
0.758 |
|
| 2002 |
Wu Z, Earle J, Saito S, Anderson CW, Appella E, Xu Y. Mutation of mouse p53 Ser23 and the response to DNA damage. Molecular and Cellular Biology. 22: 2441-9. PMID 11909939 DOI: 10.1128/Mcb.22.8.2441-2449.2002 |
0.374 |
|
| 2002 |
Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, Cheng G. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature. 416: 190-4. PMID 11894097 DOI: 10.1038/416190A |
0.519 |
|
| 2002 |
Kang J, Bronson RT, Xu Y. Targeted disruption of NBS1 reveals its roles in mouse development and DNA repair Embo Journal. 21: 1447-1455. PMID 11889050 DOI: 10.1093/Emboj/21.6.1447 |
0.356 |
|
| 2001 |
Post S, Weng YC, Cimprich K, Chen LB, Xu Y, Lee EY. Phosphorylation of serines 635 and 645 of human Rad17 is cell cycle regulated and is required for G(1)/S checkpoint activation in response to DNA damage. Proceedings of the National Academy of Sciences of the United States of America. 98: 13102-7. PMID 11687627 DOI: 10.1073/Pnas.231364598 |
0.374 |
|
| 2001 |
Sekiguchi J, Ferguson DO, Chen HT, Yang EM, Earle J, Frank K, Whitlow S, Gu Y, Xu Y, Nussenzweig A, Alt FW. Genetic interactions between ATM and the nonhomologous end-joining factors in genomic stability and development. Proceedings of the National Academy of Sciences of the United States of America. 98: 3243-8. PMID 11248063 DOI: 10.1073/Pnas.051632098 |
0.592 |
|
| 2000 |
Ellmeier W, Jung S, Sunshine MJ, Hatam F, Xu Y, Baltimore D, Mano H, Littman DR. Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk. The Journal of Experimental Medicine. 192: 1611-24. PMID 11104803 DOI: 10.1084/Jem.192.11.1611 |
0.64 |
|
| 2000 |
Chao C, Saito S, Anderson CW, Appella E, Xu Y. Phosphorylation of murine p53 at Ser-18 regulates the p53 responses to DNA damage Proceedings of the National Academy of Sciences of the United States of America. 97: 11936-11941. PMID 11035798 DOI: 10.1073/Pnas.220252297 |
0.362 |
|
| 2000 |
Chao C, Saito S, Kang J, Anderson CW, Appella E, Xu Y. p53 Transcriptional activity is essential for p53-dependent apoptosis following DNA damage Embo Journal. 19: 4967-4975. PMID 10990460 DOI: 10.1093/Emboj/19.18.4967 |
0.368 |
|
| 2000 |
Chao C, Yang EM, Xu Y. Rescue of defective T cell development and function in Atm-/- mice by a functional TCR alpha beta transgene. Journal of Immunology (Baltimore, Md. : 1950). 164: 345-9. PMID 10605029 DOI: 10.4049/Jimmunol.164.1.345 |
0.332 |
|
| 1999 |
Kuljis RO, Chen G, Lee EY, Aguila MC, Xu Y. ATM immunolocalization in mouse neuronal endosomes: implications for ataxia-telangiectasia. Brain Research. 842: 351-8. PMID 10526131 DOI: 10.1016/S0006-8993(99)01813-2 |
0.349 |
|
| 1999 |
Xu Y. ATM in lymphoid development and tumorigenesis Advances in Immunology. 72: 179-189. PMID 10361575 DOI: 10.1016/S0065-2776(08)60020-6 |
0.357 |
|
| 1999 |
Chen G, Yuan SS, Liu W, Xu Y, Trujillo K, Song B, Cong F, Goff SP, Wu Y, Arlinghaus R, Baltimore D, Gasser PJ, Park MS, Sung P, Lee EY. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. The Journal of Biological Chemistry. 274: 12748-52. PMID 10212258 DOI: 10.1074/Jbc.274.18.12748 |
0.651 |
|
| 1998 |
Xu Y, Yang EM, Brugarolas J, Jacks T, Baltimore D. Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm-/- mice. Molecular and Cellular Biology. 18: 4385-90. PMID 9632822 DOI: 10.1128/Mcb.18.7.4385 |
0.572 |
|
| 1997 |
Plug AW, Peters AH, Xu Y, Keegan KS, Hoekstra MF, Baltimore D, de Boer P, Ashley T. ATM and RPA in meiotic chromosome synapsis and recombination. Nature Genetics. 17: 457-61. PMID 9398850 DOI: 10.1038/Ng1297-457 |
0.586 |
|
| 1997 |
Kuljis RO, Xu Y, Aguila MC, Baltimore D. Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia-telangiectasia. Proceedings of the National Academy of Sciences of the United States of America. 94: 12688-93. PMID 9356511 DOI: 10.1073/Pnas.94.23.12688 |
0.589 |
|
| 1997 |
Baskaran R, Wood LD, Whitaker LL, Canman CE, Morgan SE, Xu Y, Barlow C, Baltimore D, Wynshaw-Boris A, Kastan MB, Wang JY. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature. 387: 516-9. PMID 9168116 DOI: 10.1038/387516A0 |
0.667 |
|
| 1996 |
Xu Y, Cheng G, Baltimore D. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses Immunity. 5: 407-415. PMID 8934568 DOI: 10.1016/S1074-7613(00)80497-5 |
0.677 |
|
| 1996 |
Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma Genes and Development. 10: 2411-2422. PMID 8843194 DOI: 10.1101/Gad.10.19.2411 |
0.641 |
|
| 1996 |
Xu Y, Baltimore D. Dual roles of ATM in the cellular response to radiation and in cell growth control Genes and Development. 10: 2401-2410. PMID 8843193 DOI: 10.1101/Gad.10.19.2401 |
0.613 |
|
| 1996 |
Xu Y, Davidson L, Alt FW, Baltimore D. Function of the pre-T-cell receptor alpha chain in T-cell development and allelic exclusion at the T-cell receptor beta locus. Proceedings of the National Academy of Sciences of the United States of America. 93: 2169-73. PMID 8700903 DOI: 10.1073/Pnas.93.5.2169 |
0.697 |
|
| 1996 |
Xu Y, Davidson L, Alt FW, Baltimore D. Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement. Immunity. 4: 377-85. PMID 8612132 DOI: 10.1016/S1074-7613(00)80251-4 |
0.712 |
|
| 1993 |
Chen J, Trounstine M, Kurahara C, Young F, Kuo CC, Xu Y, Loring JF, Alt FW, Huszar D. B cell development in mice that lack one or both immunoglobulin kappa light chain genes. The Embo Journal. 12: 821-30. PMID 8458340 DOI: 10.1002/J.1460-2075.1993.Tb05722.X |
0.638 |
|
| 1993 |
Xu Y, Baldassare M, Fisher P, Rathbun G, Oltz EM, Yancopoulos GD, Jessell TM, Alt FW. LH-2: a LIM/homeodomain gene expressed in developing lymphocytes and neural cells. Proceedings of the National Academy of Sciences of the United States of America. 90: 227-31. PMID 7678338 DOI: 10.1073/Pnas.90.1.227 |
0.654 |
|
| Show low-probability matches. |
